close-button

Sign in

Forgot Password?



Not signed up yet? Sign up now

close-button

Sign up for new account

IBPS Bank PO and Clerk Exam Preparation
IBPS SO
IBPS Bank PO and Clerk Exam Preparation
IBPS PO
IBPS Bank PO and Clerk Exam Preparation
IBPS Clerk
IBPS Bank PO and Clerk Exam Preparation
GMAT
IBPS Bank PO and Clerk Exam Preparation
SSC CGL-1
Railways (RRB) Preparation
Railway(RRB)


Already a member? Sign in now

close button

Forgot Password?



Remember your password? Sign in now

 

Hetero gets DGCI’s approval for hepatitis C drug

hetero-gets-dcgi-approval-to-market-hepatitis-c-drugDrug maker Hetero has received approval from DCGI to market generic version of Gilead’s Harvoni, a drug used in the treatment of Hepatitis C, in the country.

Hetero is the first company in India to receive the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from Drug Controller General of India (DCGI), the company said in a statement.

Following the non-exclusive licensing agreement signed with Gilead Sciences in September last year, to manufacture and market chronic hepatitis C medicines, Hetero is all set to launch the fixed-dose combination therapy Ledipasvir-Sofosbuvir for Indian patients, it added. Read More

Comment Here

Leave a Reply

Download our Android app to Study Anywhere, Anytime

Studycopter's Android App is used by thousands of users to practice & study for IBPS prelim and mains exams for PO, Clerk, and SO. Get it now to get a top IBPS exam score

TeacherDownload

Like our Facebook page to get exam updates, current affairs, exam tips etc.

Teacher